These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11975272)

  • 1. Access denied. While the decision over beta-interferon prescribing hangs in the balance, one thing's for certain--nurses will be left to pick up the pieces.
    Thomas S
    Nurs Stand; 2000 Jul 19-25; 14(44):20. PubMed ID: 11975272
    [No Abstract]   [Full Text] [Related]  

  • 2. Bad decision NICE.
    Ellis SJ
    Lancet; 2002 Feb; 359(9304):447. PubMed ID: 11844551
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.
    Bryant J; Clegg A; Milne R
    BMJ; 2000 May; 320(7247):1474-5; author reply 1475-6. PubMed ID: 10877569
    [No Abstract]   [Full Text] [Related]  

  • 4. A cost-utility analysis of interferon beta for multiple sclerosis.
    Parkin D; McNamee P; Jacoby A; Miller P; Thomas S; Bates D
    Health Technol Assess; 1998; 2(4):iii-54. PubMed ID: 9580870
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon beta in multiple sclerosis.
    Richards RG
    BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon-beta in multiple sclerosis--who is going to be treated?].
    Aarli JA
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3114. PubMed ID: 10522472
    [No Abstract]   [Full Text] [Related]  

  • 7. Funding of drug treatment of multiple sclerosis should not be delayed.
    Paty DW
    BMJ; 1997 Nov; 315(7116):1160-1. PubMed ID: 9374903
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis drug prompts rationing fears.
    Dyer O
    BMJ; 1995 Oct; 311(7011):969. PubMed ID: 7580631
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta interferon and multiple sclerosis: why the fuss?
    Mumford CJ
    QJM; 1996 Jan; 89(1):1-3. PubMed ID: 8730337
    [No Abstract]   [Full Text] [Related]  

  • 10. A purchaser perspective of managing new drugs: interferon beta as a case study.
    Walley T; Barton S
    BMJ; 1995 Sep; 311(7008):796-9. PubMed ID: 7580445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortcomings in pharmacy benefit forecasting--interferon beta products.
    Rich SJ; Meyer C
    J Manag Care Pharm; 2003; 9(4):373; author reply 374. PubMed ID: 14613461
    [No Abstract]   [Full Text] [Related]  

  • 12. Rebif offers another option for treating multiple sclerosis.
    Ryan M
    J Am Pharm Assoc (Wash); 2002; 42(6):889-91. PubMed ID: 12482017
    [No Abstract]   [Full Text] [Related]  

  • 13. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta interferon, NICE, and rationing.
    Kernick D
    Br J Gen Pract; 2002 Sep; 52(482):784-5. PubMed ID: 12236297
    [No Abstract]   [Full Text] [Related]  

  • 15. Health department to fund interferon beta despite institute's ruling.
    Mayor S
    BMJ; 2001 Nov; 323(7321):1087. PubMed ID: 11701567
    [No Abstract]   [Full Text] [Related]  

  • 16. Funding medicines for people with multiple sclerosis.
    Taylor D
    BMJ; 2001 Dec; 323(7326):1379-80. PubMed ID: 11744549
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of economic modeling studies in the evaluation of treatment strategies for multiple sclerosis.
    Detournay B
    Value Health; 2002; 5(1):1-2. PubMed ID: 11873378
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness analysis of interferon beta in multiple sclerosis: a Markov process analysis.
    Nuijten MJ; Hutton J
    Value Health; 2002; 5(1):44-54. PubMed ID: 11873383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis risk sharing scheme: a costly failure.
    Raftery J
    BMJ; 2010 Jun; 340():c1672. PubMed ID: 20522654
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients' views of explicit rationing: what are the implications for health service decision-making?
    Devlin N; Appleby J; Parkin D
    J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.